117
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Duration of Diabetes and Screening Coverage for Retinopathy Among Patients With Type 2 Diabetes

, &
Pages 76-79 | Received 20 Dec 2005, Accepted 20 Jun 2006, Published online: 08 Jul 2009

REFERENCES

  • Moss S E, Klein R, Klein B EK. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med. 1995; 4: 529–534
  • Schoenfeld E R, Greene J M, Wu S Y, Leske M C. Patterns of adherence to diabetes vision care guidelines. Baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001; 108: 563–571
  • Wilson A, Baker R, Thompson J, Grimshaw G. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. Diabetic Med. 2004; 21: 271–278
  • Krans H M, Porta M, Keen H. Diabetes care and research in Europe: the St. Vincent Declaration action programme. Implementation document. WHO Regional Office for Europe, Copenhagen 1992
  • Ministerio d e. Sanidad y Consumo. Documentos de los grupos de trabajo de la Conferencia Nacional de Diabetes Mellitus. Ministerio de Sanidad y Consumo, Madrid 1992
  • Ministerio de Sanidad y Consumo. Consenso para la atención a las personas con diabetes en España. Ministerio de Sanidad y Consumo, Madrid 1995
  • European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. International Diabetes Federation (European Region), BrusselsBelgium 1998
  • Hernaez-Ortega M C, Soto-Pedre E, Vázquez J A, Gutiérrez M A, Asua J. Study of the efficiency of a non-mydriatic retinal camera in the diagnosis of diabetic retinopathy (Spanish). Rev Clin Esp. 1998; 198: 194–199
  • Soto-Pedre E, Hernaez-Ortega M C, Vázquez J A. Response to Gómez-Ulla et al. Diabetes Care. 2003; 26: 963–964
  • Wilkinson C P, Ferris F L, Klein R E, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110: 1677–1682
  • Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000; 23(3)345–348
  • Snedecor G W, Cochran W G. Statistical methods. Iowa State University Press, Ames, IA 1989
  • StataCorp. Stata reference manual, release 5.0. Stata Corporation, College Station, TX 1997
  • Cavallerano A A, Cavallerano J D, Katalinic P, et al. Use of Joslin Vision Network digital-video nonmydriatic retinal imaging to assess diabetic retinopathy in a clinical program. Retina. 2003; 23: 215–223
  • National Diabetes Data Group. Diabetes in America. National Institutes of Health, Bethesda, MD 1995
  • Varma R, Torres M, Peña F, Klein R, Azen S P. Los Angeles Latino Eye Study Group. Prevalence of diabetic retinopathy in adult latinos. The Los Angeles Latino Eye Study. Ophthalmology. 2004; 111: 1298–1306
  • Arteagoitia J M, Larrañaga M I, Rodriguez J L, Fernandez I, Piniés J A. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia. 2003; 46: 899–909
  • Adamis A P, Shima D T. The role of vascular endothelial growth factor in ocular health and disease. Retina. 2005; 25: 111–118
  • Hernaez-Ortega M C, Soto-Pedre E, Beitia J J. Sandostatin LAR for cystoid diabetic macular edema: a 1 year experience. Diabetes Res Clin Pract. 2004; 64(1)71–72

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.